124 related articles for article (PubMed ID: 2712596)
1. CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and fallopian tube. I. Immunohistochemical detection.
Scharl A; Crombach G; Vierbuchen M; Müsch H; Bolte A
Arch Gynecol Obstet; 1989; 244(2):103-12. PubMed ID: 2712596
[TBL] [Abstract][Full Text] [Related]
2. CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and Fallopian tube. II. Immunoradiometric determination in secretions, tissue extracts and serum.
Crombach G; Scharl A; Würz H
Arch Gynecol Obstet; 1989; 244(2):113-22. PubMed ID: 2712597
[TBL] [Abstract][Full Text] [Related]
3. Antigen CA 19-9: presence in mucosa of nondiseased müllerian duct derivatives and marker for differentiation in their carcinomas.
Scharl A; Crombach G; Vierbuchen M; Göhring U; Göttert T; Holt JA
Obstet Gynecol; 1991 Apr; 77(4):580-5. PubMed ID: 2002982
[TBL] [Abstract][Full Text] [Related]
4. Expression of IgA and secretory component in the normal and in adenocarcinomas of Fallopian tube, endometrium and endocervix.
Lee YS; Raju GC
Histopathology; 1988 Jul; 13(1):67-78. PubMed ID: 3209192
[TBL] [Abstract][Full Text] [Related]
5. Tumor marker CA-125 in tissues of the female reproductive tract and in serum during the normal menstrual cycle.
Zeimet AG; Müller-Holzner E; Marth C; Daxenbichler G; Dapunt O
Fertil Steril; 1993 May; 59(5):1028-35. PubMed ID: 8486169
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localizations of CA 125, carcinoembryonic antigen, and CA 19-9 in normal and neoplastic glandular cells of the uterine cervix.
Nanbu Y; Fujii S; Konishi I; Nonogaki H; Mori T
Cancer; 1988 Dec; 62(12):2580-8. PubMed ID: 3191457
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical staining for CA-125 in fallopian tube carcinomas.
Puls LE; Davey DD; DePriest PD; Gallion HH; van Nagell JR; Hunter JE; Pavlik EJ
Gynecol Oncol; 1993 Mar; 48(3):360-3. PubMed ID: 8462903
[TBL] [Abstract][Full Text] [Related]
8. Tissue expression of CA 125 in benign and malignant lesions of ovary and fallopian tube: a comparison with CA 19-9 and CEA.
Neunteufel W; Breitenecker G
Gynecol Oncol; 1989 Mar; 32(3):297-302. PubMed ID: 2646183
[TBL] [Abstract][Full Text] [Related]
9. Cytokeratins of normal epithelia and some neoplasms of the female genital tract.
Moll R; Levy R; Czernobilsky B; Hohlweg-Majert P; Dallenbach-Hellweg G; Franke WW
Lab Invest; 1983 Nov; 49(5):599-610. PubMed ID: 6195450
[TBL] [Abstract][Full Text] [Related]
10. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
11. Distribution of CA 19-9 in adenocarcinomas and transitional cell carcinomas. An immunohistochemical study of 527 cases.
Loy TS; Sharp SC; Andershock CJ; Craig SB
Am J Clin Pathol; 1993 Jun; 99(6):726-8. PubMed ID: 8322708
[TBL] [Abstract][Full Text] [Related]
12. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
Onuma K; Dabbs DJ; Bhargava R
Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical distribution of tumor-associated antigen CA6 in gynecological neoplasms as detected by monoclonal antibody DS6.
Smith NL; Halliday BE; Finley JL; Wennerberg AE
Int J Gynecol Pathol; 2001 Jul; 20(3):260-6. PubMed ID: 11444202
[TBL] [Abstract][Full Text] [Related]
14. CA 125 and CA 19-9 immunolocalization in normal, hyperplastic, and carcinomatous endometrium.
Podczaski E; Kaminski PF; Zaino R
Cancer; 1993 Apr; 71(8):2551-6. PubMed ID: 8453578
[TBL] [Abstract][Full Text] [Related]
15. CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.
Costa MJ; Guinee D
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):293-9. PubMed ID: 11127921
[TBL] [Abstract][Full Text] [Related]
16. Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix.
Niloff JM; Klug TL; Schaetzl E; Zurawski VR; Knapp RC; Bast RC
Am J Obstet Gynecol; 1984 Apr; 148(8):1057-8. PubMed ID: 6201072
[TBL] [Abstract][Full Text] [Related]
17. Distribution of CA 125 in adenocarcinomas. An immunohistochemical study of 481 cases.
Loy TS; Quesenberry JT; Sharp SC
Am J Clin Pathol; 1992 Aug; 98(2):175-9. PubMed ID: 1380769
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of MUC2 and MUC5AC in benign and malignant glandular lesions of the cervix uteri.
Riethdorf L; O'Connell JT; Riethdorf S; Cviko A; Crum CP
Virchows Arch; 2000 Oct; 437(4):365-71. PubMed ID: 11097361
[TBL] [Abstract][Full Text] [Related]
19. Thyroid transcription factor-1 expression in normal gynecologic tissues and its potential significance.
Niu HL; Pasha TL; Pawel BR; LiVolsi VA; Zhang PJ
Int J Gynecol Pathol; 2009 Jul; 28(4):301-7. PubMed ID: 19483637
[TBL] [Abstract][Full Text] [Related]
20. [Immunohistochemical demonstration of CA 125, CA 19-9 and CEA in normal and pathologically changed adnexa].
Neunteufel W; Breitenecker G
Geburtshilfe Frauenheilkd; 1988 May; 48(5):334-7. PubMed ID: 3165079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
